Related Experiment Video

Updated: Mar 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.3K

Drug Screening in Neonates

Susan Givens Bell

    Neonatal Network : NN
    |September 17, 2016
    PubMed

    Insights

    Gestational substance exposure affects newborns, necessitating screening for acute care and early intervention. This review covers substance use extent, neonatal testing matrices, and legal aspects.

    Area of Science:

    • Neonatal care
    • Pharmacology
    • Public health

    Background:

    • Gestational substance exposure is a significant public health issue.
    • Neonates can be exposed to illicit, prescription, and legal substances during pregnancy.
    • Exposure can lead to teratogenic effects or neonatal dependence and withdrawal.

    Purpose of the Study:

    • To review the extent of substance use by pregnant women.
    • To provide an overview of neonatal biologic matrices for drug testing.
    • To discuss legal implications of neonatal substance screening.

    Main Methods:

    • Literature review on gestational substance exposure.
    • Analysis of neonatal drug testing matrices.
    • Discussion of legal frameworks surrounding neonatal screening.

    Main Results:

    • Substance use during pregnancy poses risks to neonates.
    • Various biologic matrices are available for neonatal drug testing.
    • Legal considerations are crucial in neonatal substance screening protocols.

    Conclusions:

    • Newborn screening for gestational substance exposure is vital for optimal outcomes.
    • Understanding substance use patterns and testing methods is essential for clinicians.
    • Legal and ethical aspects must be addressed in neonatal substance screening policies.

    More Related Videos

    A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites13:35

    A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

    Published on: March 1, 2018

    15.4K
    Neurodevelopmental Reflex Testing in Neonatal Rat Pups09:35

    Neurodevelopmental Reflex Testing in Neonatal Rat Pups

    Published on: April 24, 2017

    21.2K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    349
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    312
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    631
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    419